Pelvic Inflammatory Disease Occurring between the Time of Testing and Treatment for Gonorrhoea and Chlamydia

pathogens at both visits (p<0.001 for all, Abstract O1-S04.05 table 1). Overall annual incidence rates (per 1,000, 95% CI), based on results of the 934 (96%) students who attended the 42M/54M visits (934 urine, 931 serology tests), were substantially higher in females compared to males [males: GC 18.4 (8.7e36.6), CT 73.7 (52.4e102.5), TV 0.0 (0.0e10.6), HSV-2 28.6 (15.9e59.9); females: GC 76.0 (55.6e102.8), CT 184.0 (152.7e220.4), TV 40.0 (25.7e61.3), HSV-2 64.4 (44.9e91.3)]. Incidence rates were also calculated for students (311 females, 66%; 334 males, 77%) who reported ever having had vaginal intercourse (Abstract O1-S04.05 table 1). Compared to overall rates, females had significantly higher rates for each STI (GC/CT, p<0.001; TV, p 1⁄40.027; HSV-2, p 1⁄40.015); this was not the case for males. Conclusions This community-based screening study demonstrates an extremely high STI burden among youth in the Eastern Cape Province of South Africa.